Who owns MOLECULIN BIOTECH INC?
- Ticker: MBRX
- CUSIP Number: 60855d408
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 23k | $75k | 100% | Dec 2025 |
|
| Vanguard Group | 16k | $51k | 100% | Dec 2025 |
|
| Geode Capital Management | 15k | $50k | 100% | Dec 2025 |
|
| UBS Group | 5.9k | $19k | 100% | Dec 2025 |
|
| Tower Research Capital | 1.4k | $4.6k | 100% | Dec 2025 |
|
| BlackRock | 495.00 | $1.6k | 100% | Dec 2025 |
|
| EFG International | 434.00 | $1.4k | 100% | Dec 2025 |
|
| Pinnacle Wealth Planning Services | 281.00 | $929.997600 | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 218.00 | $721.994200 | 100% | Dec 2025 |
|
| Newbridge Financial Services Group | 114.00 | $376.998000 | 100% | Dec 2025 |
|
| SBI Securities | 29.00 | $95.998700 | 100% | Dec 2025 |
|
| Danske Bank A/s | 2.00 | $7.000000 | 100% | Dec 2025 |
|
| CVA Family Office | 1.00 | $3.000000 | 100% | Dec 2025 |
|
| Advisor Group Holdings | 1.00 | $3.000000 | 100% | Dec 2025 |
|